There is a concern that the numbers of MRSA or other antimicrobial-resistant bacteria might increase further when human isolates become established in animals, as this can amplify the numbers of such bacteria by dissemination within animal groups with subsequent spread back to humans. Certain antimicrobials have been implicated in the selection of MRSA, ESBL-producing bacteria and predisposition to infection by C. difficile. Guidelines for treatment and prevention of infections by MRSA, ESBL-producing bacteria and C. difficile were discussed and evidence-based policies were recommended for both humans and animals.
MRSA News- Persistent MRSA - Why some people are more vulnerable
- Progress Made in Developing Community-Acquired MRSA Vaccine
- MRSA Found in Antibiotic-free Meat
- Why Community MRSA Will Dominate
- MRSA: Risk Factors for Household Transmission
- U.K. Court Upholds $1.3 Million Damages Ruling Against 3M in MRSA Case
- USA300 Getting More Lethal
- 1000 USA300 cases in UK last year
- Commercially distributed meat and community MRSA
- Optimizing Antibiotic Regimens to Counter Antibiotic Resistance
- Epidemic impetigo and MRSA
- Linezolid better than vancomycin for MRSA?
- Genetic change: a Case Study of Staphylococcus aureus
- Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated From Pets Living in Households With MRSA-Infected Children
- Severe Neutropenia and Long Term Vancomycin Treatment
- How Staphylococcus aureus biofilms develop their characteristic structure
- Scottish MRSA rate at 'lowest levels since records began'
- Four Key Risk Factors for HA-MRSA Infection in ICU
- Resistant Bacteria Found in Poultry Meat
- Reducing the development of antibiotic resistance